Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.

Qibin HuangHongli XuXi WangJiangfeng MaoBingqing YuYiyi ZhuRui ZhangBang SunJunyi ZhangWen JiWanlu MaBang Sun Xueyan Wu

Published in: Clinical endocrinology (2022)

NAFLD is a frequent comorbidity among Chinese adult patients with PSIS and is strongly associated with lower IGF-1 levels. Timely and appropriate hormone replacement, particularly growth hormone may contribute to decreasing the risk of NAFLD in these patients.

Keyphrases

growth hormone
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
case report
replacement therapy
signaling pathway
pi k akt